Takeda Pharmaceutical Company Limited - BDR (TAKP34)
Market Closed
7 Aug, 19:55
B3 B3 Primary R$
89. 98
0
0%
R$
287.35B Market Cap
37.11 P/E Ratio
2.85% Div Yield
33 Volume
0 Eps
R$ 89.98
Previous Close Want to track TAKP34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Takeda Pharmaceutical Company Limited - BDR (TAKP34) Statistics
Valuation metrics
Market Cap 287.35B
Enterprise value 162.56B
Trailing P/E (ttm) 40.38
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.05
Price/Book (mrq) 0.95
Enterprise Value/Revenue 1.13
Enterprise Value/EBITDA 3.79
Overview
Shares outstanding 1.58B
Float 3.16B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1
Average volume (90 days) 4
Price summary
52-Week low 70.8
52-Week high 95.3
Beta 0.09
50-Day moving average 82.3
200-Day moving average 83.38
Dividends and splits
Forward annual dividend rate 2.85
Forward annual dividend yield 0.0373%
Trailing annual dividend rate 2.84
Trailing annual dividend yield 0.0372%
5-Year annual dividend yield 4.29%
Payout ratio 1.38
Dividend Date 17 Dec 2025
Ex-Dividend Date 26 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.04%
Operating margin 0.03%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) 143.61B
Revenue per share (ttm) 1,430.33
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 93.52B
EBITDA 1.19T
Net income to common (ttm) 6.11B
Diluted EPS (ttm) 1.89
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) 18.97B
Total cash per share (mrq) 188.33
Total debt (mrq) 173.81B
Total Debt/Equity (mrq) 70.14
Current ratio (mrq) 1.27%
Book value per share (mrq) 79.96
Cash Flow
Cash flow statement 33.19B
Levered free cash flow (LFCF) 11.37B
